Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Acetyl L-carnitine (ALCAR) is supported by some scientific evidence for its potential in mitigating free radical damage, though the strength of evidence is moderate and largely based on preclinical and small clinical studies. ALCAR is an acetylated form of L-carnitine that readily crosses the blood-brain barrier and plays a role in mitochondrial energy metabolism. Several in vitro and animal studies have demonstrated that ALCAR can reduce markers of oxidative stress and enhance antioxidant enzyme activity, such as increasing superoxide dismutase and glutathione levels. This suggests that ALCAR may help to neutralize free radicals and protect cells from oxidative damage. In human studies, evidence is more limited but promising. Some small clinical trials have shown that ALCAR supplementation may reduce oxidative stress markers in older adults and individuals with neurodegenerative diseases. For example, in patients with Alzheimer’s disease and mild cognitive impairment, ALCAR has been reported to decrease lipid peroxidation products, indicating a reduction in oxidative damage. However, larger and more robust clinical trials are still needed to firmly establish its efficacy for this purpose. Overall, while ALCAR is not traditionally used for free radical damage, there is a growing body of scientific literature indicating its potential antioxidant effects. The current evidence suggests a modest benefit, but further research is required to confirm its therapeutic role in oxidative stress-related conditions.

More about acetyl l-carnitine
More about Free Radical Damage

Other ingredients used for Free Radical Damage

Other health conditions supported by acetyl l-carnitine

Products containing acetyl l-carnitine

Nature's Sunshine Solstic Cardio